Development and Characterization of Excipient Enhanced Growth (EEG) Surfactant Powder Formulations for Treating Neonatal Respiratory Distress Syndrome

被引:0
作者
Susan Boc
Mohammad A. M. Momin
Dale R. Farkas
Worth Longest
Michael Hindle
机构
[1] Virginia Commonwealth University,School of Pharmacy, Department of Pharmaceutics
[2] Virginia Commonwealth University,Department of Mechanical & Nuclear Engineering
来源
AAPS PharmSciTech | / 22卷
关键词
surfactant; excipient enhanced growth; powder aerosol; leucine; trileucine;
D O I
暂无
中图分类号
学科分类号
摘要
This study aimed to develop and characterize a spray-dried powder aerosol formulation of a commercially available surfactant formulation, Survanta® intratracheal suspension, using the excipient enhanced growth (EEG) approach. Survanta EEG powders were prepared by spray drying of the feed dispersions containing Survanta® (beractant) intratracheal suspension, hygroscopic excipients (mannitol and sodium chloride), and a dispersion enhancer (l-leucine or trileucine) in 5 or 20% v/v ethanol in water using the Buchi Nano Spray Dryer B-90 HP. Powders were characterized for primary particle size, morphology, phospholipid content, moisture content, thermal properties, moisture sorption, and surface activity. The aerosol performance of the powders was assessed using a novel low-volume dry powder inhaler (LV-DPI) device operated with 3-mL volume of dispersion air. At both ethanol concentrations, in comparison to trileucine, l-leucine significantly reduced the primary particle size and span and increased the fraction of submicrometer particles of the Survanta EEG powders. The l-leucine-containing Survanta EEG powders exhibited good aerosolization performance with ≥ 88% of the mass emitted (% nominal) after 3 actuations from the modified LV-DPI device. In addition, l-leucine-containing powders had a low moisture content (< 3% w/w) with transition temperatures close to the commercial surfactant formulation and retained their surface tension reducing activity after formulation processing. A Survanta EEG powder containing l-leucine was developed which showed efficient aerosol delivery from the modified LV-DPI device using a low dispersion air volume.
引用
收藏
相关论文
共 224 条
[61]  
Merritt TA(undefined)undefined undefined undefined undefined-undefined
[62]  
Bernstein G(undefined)undefined undefined undefined undefined-undefined
[63]  
Job L(undefined)undefined undefined undefined undefined-undefined
[64]  
Mazela J(undefined)undefined undefined undefined undefined-undefined
[65]  
Segal R(undefined)undefined undefined undefined undefined-undefined
[66]  
Jorch G(undefined)undefined undefined undefined undefined-undefined
[67]  
Hartl H(undefined)undefined undefined undefined undefined-undefined
[68]  
Roth B(undefined)undefined undefined undefined undefined-undefined
[69]  
Kribs A(undefined)undefined undefined undefined undefined-undefined
[70]  
Gortner L(undefined)undefined undefined undefined undefined-undefined